Real-World Success Stories

Discover how we have helped pharmaceutical and healthcare companies optimize their tendering strategies, expand into new markets, and drive significant revenue growth. We serve generic pharmaceutical companies, MedTech manufacturers, tender and bid teams, and healthcare organizations worldwide.

Who We Serve

Case Study: Product Portfolio Optimization for Generics Manufacturer

A leading generics company engaged us to analyze their product portfolio and identify strategic opportunities for growth and optimization.

What We Did

• Portfolio Analysis: Comprehensive review of all products across all tendered markets to identify underperformers and high-potential opportunities
• Strategic Recommendations: Identified products to discontinue (freeing up resources) and products with room for significant improvement after formulation changes
• Market Intelligence: Provided data-driven insights on competitive landscape and pricing dynamics in each market

Results Achieved

• +20% Revenue Increase from optimized product portfolio and better market targeting
• +35% Profit Margin Improvement through strategic product changes and pricing optimization

Case Study: B2B Manufacturer Partner Enablement

A generics manufacturer that does not participate in tenders directly but sells to distribution partners who handle tendering needed better market intelligence to support their partners and optimize their own pricing.

What We Did

• Partner Success: Our analysis helped their distribution partners win more tenders by providing pricing intelligence and competitive data
• Profit Margin Visibility: Determined profit margins of their sellers/partners to optimize pricing strategy per client — understanding what distributors actually make on each tender
• Data-Backed Negotiations: Commercial teams gained hard data to support pricing discussions and partnership negotiations
• Production Planning: Better manufacturing forecasts by knowing upcoming tender opportunities and expected volumes

Key Outcomes

• Higher partner win rates through better pricing support
• Optimized margin analysis revealing actual partner profitability
• Improved production planning aligned with tender timelines

Case Study: Market Access Analysis for Branded Pharma and MedTech

We do not only help generics firms. Our expertise extends to market analysis for market access for MedTech and pharmaceutical companies with branded products. Tender data is published even for non-generics products, allowing comprehensive market tracking.

What We Did

• Medical Device Intelligence: Helped a MedTech manufacturer determine which European markets are best suited for their specific product range
• Competitive Intelligence: Tracked market dynamics, pricing, and competitor activity across therapeutic areas for branded pharmaceuticals
• Market Sizing: Provided comprehensive tender volume and value analysis by product category and country

Our expertise covers: Generic Pharmaceuticals (our core), Branded Pharmaceuticals (market access and tender tracking), and Medical Devices (procurement intelligence).

Case Study: Asian Medical Supplies Manufacturer - European Market Entry

An Asian manufacturer of bandages, wound care products, gauze, and dressing kits wanted to enter the European market strategically but had no European presence or market knowledge.

What We Did

• Product Strategy: Analyzed European demand patterns to guide what products to manufacture for maximum market fit — not all products sell equally well in all markets
• Market Intelligence: Provided comprehensive tender data to identify which European countries have the highest demand for their specific product categories
• Partner Network: Helped find and connect with the right distribution partners in target markets to execute the European strategy
• End-to-End Support: Not just selling products, but enabling successful market entry — from product adaptation to partner selection to first sales

Services Provided

• Market Strategy: Product-market fit analysis and country prioritization
• Sales Support: Go-to-market strategy and tender pipeline development
• Partner Identification: Distributor screening, evaluation, and introduction

Case Study: Spanish Prosthetics Company - European and GCC Expansion

A Spanish prosthetics manufacturer that only operated domestically sought our expertise to expand beyond Spain's borders into the broader European market and eventually the Gulf region.

Expansion Journey

1. Spain Only: Initial domestic market presence with no international sales or tender participation
2. EU Expansion: After our market analysis and partner identification, now successfully selling products throughout the European Union
3. GCC Market Entry: Currently preparing to enter Gulf Cooperation Council (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman) markets with our continued support and market intelligence

What We Did

• Comprehensive tender and market intelligence across EU countries to identify the highest-potential markets
• Connected them with distribution partners in target countries
• Provided ongoing tender monitoring and competitive intelligence to support their expansion

More Than Just Software

We do not just sell you a product — we help you find the right partners, develop winning strategies, and execute successfully in new markets. Our team combines deep pharmaceutical industry expertise with AI technology to deliver real business results.

• Market Intelligence: Comprehensive tender data and competitive insights across all major markets and therapeutic areas
• Strategic Consulting: Bespoke consulting services to help you optimize portfolios, enter new markets, and maximize profitability
• Partner Network: Connect with the right distribution and commercial partners to successfully execute your strategy

Case Study: Post-LoE Market Entry Strategy for Generics Company

A top-20 generics manufacturer needed to develop optimal market entry strategies for multiple molecules losing patent protection across European markets.

The Challenge

With multiple LoE opportunities approaching simultaneously, the company needed data-driven guidance on which markets to enter first, how to price competitively without over-discounting, and how to anticipate competitor entry patterns. Traditional Excel-based pricing models were too slow and too inaccurate for the rapidly changing post-LoE landscape.

What We Did

• Analyzed historical price erosion curves for similar molecules across 15+ European markets
• Mapped competitor filing patterns and anticipated generic entry timelines for each molecule
• Used AI pricing models to recommend optimal entry prices balancing market share capture with margin protection
• Provided ongoing tender monitoring and competitive intelligence during the launch phase

Results

• Won first-wave tenders in 8 out of 12 target markets
• Achieved 15% higher margins than company average for LoE launches
• Reduced time-to-tender from 4 weeks to 1 week with AI-powered preparation

Case Study: Biosimilar Market Intelligence for Global Pharma

A global pharmaceutical company launching a biosimilar portfolio across Europe needed comprehensive tender intelligence to compete effectively against established originators and first-wave biosimilar entrants.

What We Provided

• Tracked originator vs. biosimilar award patterns across all major European markets
• Analyzed hospital switching policies and formulary inclusion rates by country
• Provided pricing intelligence showing biosimilar discount ranges relative to originator prices
• Monitored tender evaluation criteria specific to biosimilars (supply security, pharmacovigilance, interchangeability)

Outcome

The company successfully launched their biosimilar portfolio in 10 European markets within 18 months, achieving above-market average win rates in hospital tenders and establishing a strong competitive position in the biosimilar segment.

Ready to Write Your Success Story?

Discover how RGS Healthcare Solutions can help you optimize your tendering strategy and expand into new markets.